Erectile dysfunction is a common worldwide clinical problem, with tens of thousands of new cases per year. Worldwide, the affected population is predicted to increase from 152 million in 1995 to 322 million in 2025. The most common risk factors and medical comorbidities are smoking, obesity, type 2 diabetes, hypertension, dyslipidaemia, Coronary artery disease (CAD) and depression. Pharmax will produce a range of high-quality treatments to support the regions medical specialists.


Molecule : Tadalafil

Available Strength : 5mg, 20mg


Molecule : Sildenafil

Available Strength : 50mg, 100mg

Copyright 2020 – Pharmax Pharmaceuticals FZ-LLC. All Rights Reserved.

Ministry of Health Health and Prevention Advertisement License No : IN0W3681-140720 valid till 15/07/2021